SOUTH SAN FRANCISCO, CA, USA I 13, 2024 I TRex Bio, Inc. (“TRexBio”), a biotechnology company decoding human tissue immune biology to create ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

TRex Bio, a California biotechnology company that’s partnered with Eli Lilly and Johnson & Johnson ... TRB-061, its candidate for atopic dermatitis, targets a receptor found on Tregs in the skin and ...

Amgen is testing MariTide as a once-monthly shot, making it a promising potential rival to the weekly blockbuster weight-loss injections from Novo Nordisk and Eli Lilly. Tuesday's stock decline lopped ...

Truist Financial analyst Srikripa Devarakonda maintained a Buy rating on Protagonist Therapeutics (PTGX – Research Report) yesterday and ...

The agency said that between its spinoff from Eli Lilly in 2019 and early 2020, Elanco used discounts and rebates to entice ...

The drug developed by U.S. pharmaceutical giant Eli Lilly and Co. will be offered to patients experiencing ... or possibly ...

BioCrossroads has named Eli Lilly CEO, Dave Ricks, the recipient of the 2024 August M. Watanabe Life Sciences Champion of the ...

A Trinity Life Sciences report found that more pharma product launches were successful in 2023 than the year before. Here are ...

From left, Bill Walters, Mark Shields, Danielle Nolan, Kate Nolan, Alice Susemichel, John Elliott holding the check for ...

Almost all cases of ALS and half of frontotemporal dementia (FTD) cases are linked to dysfunction in a protein TDP-43.

Investors looking for stocks in the Large Cap Pharmaceuticals sector might want to consider either Novartis (NVS) or Eli Lilly (LLY). But which of these two companies is the best option for those ...